Interview of Prof. Meunier for EJC News Focus

Director General Françoise Meunier discusses the challenges faced today by clinical researchers in cancer. She outlines key changes needed in the ongoing revision of the Clinical Trials Directive – in particular, the need for a risk-based approach to trials, and for Member States to harmonise their implementation of the Directive – and she describes the essential features of a suggested new partnership between academia and industry. She also covers the role EORTC will continue to play in developing the early careers of investigators.

 

Back to news list